Document is current
Any future updates will be listed below
-
Authors
Ehlers, Femke A. I.
Mahaweni, Niken M.
van de Waterweg Berends, Annet
Saya, Thara
Bos, Gerard M. J.
Wieten, Lotte https://orcid.org/0000-0002-4503-1623
- License Information
-
More Information
Article History
Received: 9 February 2022
Accepted: 30 December 2022
First Online: 19 January 2023
Declarations
:
: G. M. J. Bos is Chief Executive Officer/Chief Medical Officer/Co-founder of CiMaas, BV, Maastricht, The Netherlands. CiMaas is producing an ex vivo expanded NK cell product that will be used to treat myeloma patients. The other authors declare no conflict of interest.
